Alignment Healthcare to Present in Baird 2026 Global Healthcare Conference and Attend Morgan ...
Alignment Healthcare (NASDAQ: ALHC) announced its participation in two upcoming healthcare conferences in New York. The company will present at the Baird 2026 Global Healthcare Conference on September 15th and attend the Morgan Stanley 24th Annual Global Healthcare Conference on September 16th. Alignment Healthcare focuses on empowering seniors with high-quality, low-cost care through its Medicare Advantage plans, coordinated care model, and proprietary technology.
Alignment Healthcare to Present in Baird 2026 Global Healthcare Conference and Attend Morgan Stanley 24th Annual Global Healthcare Conference
Alignment Healthcare (NASDAQ: ALHC) announced its participation in two upcoming healthcare conferences in New York. The company will present at the Baird 2026 Global Healthcare Conference with a fireside chat on September 15th and attend the Morgan Stanley 24th Annual Global Healthcare Conference on September 16th. A webcast of the Baird presentation will be available on Alignment's investor relations website.
Kaplan Fox Alerts Investors: Alignment Healthcare, Inc. (NASDAQ: ALHC) is Under Investigation for Potential Securities Law Violations
Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations after a whistleblower alleged accounting irregularities artificially inflated the company's financial results, including Adjusted EBITDA. Following this news on July 8, 2026, Alignment Healthcare's stock price dropped significantly. The law firm is seeking investors who suffered losses or have information to assist in the investigation.
Kaplan Fox Alerts Investors: Alignment Healthcare, Inc. (NASDAQ: ALHC) is Under Investigation for Potential Securities Law Violations
Kaplan Fox & Kilsheimer LLP is investigating potential securities law violations against Alignment Healthcare, Inc. (NASDAQ: ALHC) following a whistleblower complaint. The complaint alleges accounting irregularities that artificially inflated the Company's financial results and executive compensation. Following this news, Alignment Healthcare's stock price dropped significantly.
Alignment Healthcare stock hits 52-week low at $13.05
Alignment Healthcare (ALHC) stock recently hit a new 52-week low of $13.05, representing a significant year-to-date and six-month decline. Despite this, InvestingPro suggests the stock is oversold and potentially undervalued, with analysts setting higher price targets. The company reported strong Q2 2026 earnings, exceeding expectations, but faced a slight revenue miss and a downgrade from Raymond James due to concerns about expansion-related earnings visibility.
Alignment Healthcare (ALHC) president holds 917K shares after 10b5-1 sale
Alignment Healthcare (ALHC) President Dawn Christine Maroney sold 5,000 shares of common stock at $14.00 per share on August 14, 2026, under a prearranged Rule 10b5-1 trading plan adopted on March 13, 2026. Following this transaction, Maroney directly holds 917,313 shares of ALHC common stock. This insider trading activity was reported in a Form 4 filing, providing transparency into executive stock movements.
Kaplan Fox Encourages Investors of Alignment Healthcare, Inc. (NA
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (NASDAQ: ALHC) after a former executive filed a whistleblower complaint alleging accounting irregularities. The complaint claims the company "artificially inflated" its financial results, including Adjusted EBITDA, by misclassifying millions in operating expenses as capital expenditures. This news led to a significant drop in Alignment Healthcare's stock price, and Kaplan Fox is encouraging affected investors to contact the firm.
Alignment files motion to dismiss whistleblower lawsuit
Alignment Healthcare has filed a motion to dismiss a whistleblower lawsuit against it. The article, published on August 18, 2026, also mentions other recent healthcare news, including Epic's new AI tools, hospital cost-cutting strategies, and mergers and acquisitions in the health sector.
The Bull Case For Alignment Healthcare (ALHC) Could Change Following Its Top Medicare Advantage Pick Recognition
Alignment Healthcare (ALHC) has been recognized as a top Medicare Advantage pick due to strong revenue growth, improving profitability, and a solid net cash position. This recognition supports the company's investment narrative of converting tech-enabled Medicare Advantage models into durable profitability, despite potential regulatory pressures. While the recent Q2 2026 earnings showed continued revenue growth and raised full-year guidance, investors are cautioned about growing policy debates around Medicare Advantage.
Assenagon Asset Management S.A. Reduces Stake in Alignment Healthcare, Inc. $ALHC
Assenagon Asset Management S.A. significantly reduced its stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 73.9% in the second quarter, selling 113,013 shares and retaining 39,833 shares valued at approximately $948,000. Despite this, institutional investors collectively own 86.19% of the company. Alignment Healthcare exceeded quarterly expectations with $0.17 EPS and $1.34 billion in revenue, and analysts maintain a "Moderate Buy" consensus with an average price target of $23.60.
GSA Capital Partners LLP Acquires Shares of 86,412 Alignment Healthcare, Inc. $ALHC
GSA Capital Partners LLP has acquired 86,412 shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) valued at approximately $2.06 million during the second quarter. This move comes as institutional investors now collectively own 86.19% of the company, despite recent insider sales totaling over $18 million. Alignment Healthcare reported strong Q2 earnings, beating analyst estimates with $0.17 EPS and a 31.6% increase in revenue year-over-year, yet its stock trades near its 12-month low.
Kaplan Fox Reminds Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors of an Ongoing Securities Law Investigation
Kaplan Fox & Kilsheimer LLP is investigating potential securities law violations against Alignment Healthcare, Inc. following allegations of accounting irregularities that artificially inflated the company's financial results. A whistleblower complaint claims "millions of dollars in operating expenses had been systematically misclassified as capital expenditures." Following this news, Alignment Healthcare's stock price dropped significantly on July 8, 2026.
Kaplan Fox is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for Possible Securities Law Violations
Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations following a whistleblower complaint. The complaint alleges accounting irregularities that artificially inflated the company's financial results and a key non-GAAP metric, Adjusted EBITDA, leading to a significant stock price drop on July 8, 2026. Investors who suffered losses are encouraged to contact Kaplan Fox for more information.
Is It Too Late to Buy Alignment Healthcare Inc (ALHC) After 3.7% Rally? GF Value Says Undervalued
Alignment Healthcare Inc (ALHC) saw a 3.7% stock rally, yet its current price of $13.96 remains 31.9% below its GF Value™ estimate of $20.50, indicating it is undervalued. Despite a strong GF Score™ of 79/100, driven by excellent growth potential (10/10), the company faces profitability challenges (4/10) and significant insider selling. Investors are advised to consider the undervaluation alongside recent stock declines and insider activities.
ALHC filer Dawn Maroney (ALHC) plans 5,000-share sale after prior 10b5-1 trades
Dawn Maroney, a shareholder associated with Alignment Healthcare (ALHC), has filed a Rule 144 notice to sell 5,000 shares of common stock valued at $67,300 through Morgan Stanley Smith Barney LLC. This planned sale follows several prior 10b5-1 plan sales by Maroney, totaling 237,068 shares, including a significant sale of 177,068 shares for over $3.6 million in July 2026. The shares involved in the current filing are related to RSU/PSU awards from September 2020.
Kaplan Fox is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) on Behalf of Investors
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. following a whistleblower complaint. The complaint alleges accounting irregularities that artificially inflated the company's financial results, specifically Adjusted EBITDA. This news led to a significant drop in Alignment Healthcare's stock price on July 8, 2026.
ALHC5941479 Bond Profile — Key Metrics
This article provides key metrics for the ALHC5941479 bond issued by Alignment Healthcare, Inc. The bond has a 4.25% coupon rate and matures on November 15, 2029. Alignment Healthcare is described as a holding company that offers customized healthcare solutions, primarily Medicare Advantage plans, to seniors and the chronically ill.
Kaplan Fox Urges Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors to Contact the Firm Regarding a Securities Investigation
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations by Alignment Healthcare, Inc. following a whistleblower complaint. The complaint alleges accounting irregularities that artificially inflated the company's financial results, specifically Adjusted EBITDA, by misclassifying millions in operating expenses as capital expenditures. This news led to a 16.7% drop in Alignment Healthcare's stock price on July 8, 2026.
Kaplan Fox Urges Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors to Contact the Firm Regarding a Securities Investigation
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (NASDAQ: ALHC) following allegations of "accounting irregularities" that "artificially inflated" the company's reported financial results. A whistleblower complaint claims that operating expenses were systematically misclassified as capital expenditures. This news led to a significant drop in Alignment Healthcare's stock price, and Kaplan Fox is urging affected investors to contact their firm for the ongoing securities investigation.
Invesco Ltd. (ALHC) reports beneficial ownership of 10.4M Alignment Healthcare shares
Invesco Ltd. has reported beneficial ownership of 10,365,640 shares of Alignment Healthcare Inc. common stock, representing 5.0% of the outstanding class. The shares are held by clients of Invesco's advisory entities, with Invesco retaining sole voting power over 9,985,762 shares and sole dispositive power over all 10,365,640 shares. No single client holds more than a 5% economic interest in these securities.
Securities Fraud Investigation Into Alignment Healthcare, Inc. (NASDAQ: ALHC) Following Whistleblower Lawsuit Of Financial Manipulation Continues
Glancy Prongay Wolke & Rotter LLP is continuing its investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) following allegations of federal securities law violations. This comes after a whistleblower lawsuit filed by a former executive claimed the company manipulated its finances by misclassifying operating expenses as capital expenditures to artificially inflate adjusted EBITDA. The news led to a 16.7% drop in Alignment's stock price on July 8, 2026, causing injury to investors.
Kaplan Fox Advises Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) of an Investigation Into Potential Securities Law Violations
Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations after a whistleblower alleged "accounting irregularities" artificially inflated the company's financial results. The complaint claims millions in operating expenses were misclassified as capital expenditures, leading to a significant stock drop on July 8, 2026. Investors who suffered losses are encouraged to contact Kaplan Fox for more information on the investigation.
Kaplan Fox Advises Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) of an Investigation Into Potential Securities Law Violations
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (NASDAQ: ALHC) after a whistleblower complaint alleged accounting irregularities that artificially inflated the company's financial results. The complaint claims that millions of dollars in operating expenses were misclassified as capital expenditures. Following this news, Alignment Healthcare's stock price dropped by 16.7% on July 8, 2026.
Alignment Healthcare (ALHC) Stock Drops 16.7% After Whistleblower Accounting Allegations Trigger Securities Investigation
Shares of Alignment Healthcare (ALHC) dropped 16.7% following the announcement of a securities investigation by Kaplan Fox & Kilsheimer LLP. This investigation stems from a whistleblower complaint by a former executive alleging accounting irregularities, specifically the systematic misclassification of operating expenses as capital expenditures to artificially inflate Adjusted EBITDA. The law firm is now seeking investors who suffered losses and individuals with relevant information regarding these allegations.
Bank of America Corp DE Purchases 1,961,778 Shares of Alignment Healthcare, Inc. $ALHC
Bank of America Corp DE significantly increased its stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 156.5% during the first quarter, acquiring an additional 1.96 million shares. This brings their total holding to 3.22 million shares, valued at approximately $56.7 million, representing 1.56% of the company. The move comes as Alignment Healthcare reported strong quarterly revenues of $1.34 billion, up 31.6% year-over-year, and beat analyst earnings estimates, despite recent insider selling and a stock price near its 52-week low.
Alignment healthcare CEO John Kao sells $4.14m in company stock
John E. Kao, CEO of Alignment Healthcare, sold 298,000 shares of company stock for $4.14 million on August 10, 2026, under a Rule 10b5-1 trading plan. Despite the stock trading near its 52-week low and a 30% year-to-date decline, InvestingPro analysis suggests the stock is undervalued with strong revenue growth. The company recently exceeded Q2 2026 adjusted EPS expectations but slightly missed revenue, leading Raymond James to downgrade its stock rating due to concerns over expansion-related investment spending.
Alignment Healthcare upgraded to Buy after strong Q2 results and 40%+ upside potential despite valuation drop.
Alignment Healthcare has been upgraded from Hold to Buy following a significant valuation-driven price drop, despite strong Q2 operational performance including record-low medical benefits ratio and substantial membership and EBITDA growth. The company also raised its full-year guidance, with the stock currently trading at a valuation that suggests over 40% upside potential. Investors are advised to consider building positions on weakness, anticipating potential volatility from a soft Q3 guide.
Alignment healthcare CEO John Kao sells $4.14m in company stock
John E. Kao, CEO of Alignment Healthcare, sold 298,000 shares of company stock for over $4.1 million, executed under a Rule 10b5-1 trading plan. This sale comes as the stock trades near its 52-week low and after mixed Q2 2026 financial results, which included an earnings beat but a slight revenue miss, and a downgrade from Raymond James due to concerns over earnings visibility.
Insider Selling: Alignment Healthcare (NASDAQ:ALHC) CEO Sells 298,000 Shares of Stock
Alignment Healthcare (NASDAQ:ALHC) CEO John Kao sold 298,000 shares of the company's stock for approximately $4.14 million, reducing his direct ownership by 27.37%. This transaction occurred despite the company exceeding Q2 earnings expectations with $0.17 EPS and a 31.6% increase in revenue. Analysts maintain a "Moderate Buy" rating with an average price target of $23.60, though some have recently lowered their targets or downgraded the stock.
Kaplan Fox Announces an Investigation Into Alignment Healthcare
Kaplan Fox & Kilsheimer LLP has announced an investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) regarding potential securities law violations. This follows news of a whistleblower complaint alleging "accounting irregularities" that artificially inflated the company's financial results, specifically Adjusted EBITDA. Following this revelation, Alignment Healthcare's stock price dropped significantly by 16.7%.
Kaplan Fox & Kilsheimer LLP is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for Possible Securities Law Violations
Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations. This follows a whistleblower complaint alleging "accounting irregularities" that "artificially inflated" the company's financial results and a key non-GAAP metric, Adjusted EBITDA. Following the news of the complaint, Alignment Healthcare's stock price dropped by 16.7%.
Kaplan Fox & Kilsheimer LLP is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for Possible Securities Law Violations
Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations following a whistleblower complaint. The complaint alleges "accounting irregularities" and that the company "artificially inflated" its financial results, specifically Adjusted EBITDA, by misclassifying operating expenses as capital expenditures. This news led to a significant drop in Alignment Healthcare's stock price on July 8, 2026.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alignment Healthcare, Inc. - ALHC
Pomerantz LLP is investigating potential securities fraud claims against Alignment Healthcare, Inc. (ALHC) following allegations by a former executive of "accounting irregularities." The whistleblower complaint suggests the company artificially inflated its financial results, including Adjusted EBITDA, by misclassifying operating expenses as capital expenditures. This news led to a significant 16.7% drop in Alignment's stock price on July 8, 2026.
Alignment Healthcare, Inc. (ALHC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Alignment Healthcare, Inc. (ALHC) following allegations of accounting irregularities that artificially inflated the company's financial results. A former executive filed a whistleblower complaint, leading to a significant drop in Alignment's stock price on July 8, 2026. The firm encourages investors who purchased Alignment securities to contact them to assist with the investigation.
Lowey Dannenberg, P.C. is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for Potential ...
Lowey Dannenberg P.C. is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential federal securities law violations. This follows a whistleblower lawsuit alleging the company manipulated its finances by misclassifying operating expenses as capital expenditures to inflate its adjusted EBITDA. The lawsuit claims this artificial inflation allowed Alignment to report its first full year of positive adjusted EBITDA, leading to a significant drop in stock price after the news broke.
Kaplan Fox Encourages Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) to Contact the Firm to Learn About Their Legal Rights
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (NASDAQ: ALHC) after news emerged of a whistleblower complaint. The complaint alleges accounting irregularities that artificially inflated the company's financial results and executive compensation. Following this news, Alignment Healthcare's stock price dropped significantly.
ALHC INVESTOR ALERT: Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors Urged to Contact Hagens Berman; Investigation Opened Following Disappointing Second-Quarter Results and Whistleblower Allegations
Hagens Berman Sobol Shapiro LLP has initiated an investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) following disappointing second-quarter 2026 financial guidance and serious whistleblower allegations. The investigation focuses on potential securities law violations, specifically concerning whether the company misled investors about profitability and expense management, exacerbated by a whistleblower claiming misclassification of operating expenses as capital expenditures. Investors who suffered substantial losses are encouraged to contact Hagens Berman to discuss their legal rights.
Kaplan Fox Encourages Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) to Contact the Firm to Learn About Their Legal Rights
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (NASDAQ: ALHC) following allegations of "accounting irregularities" and artificially inflated financial results. A whistleblower complaint claims that millions in operating expenses were misclassified as capital expenditures. The news led to a 16.7% drop in Alignment Healthcare's stock price on July 8, 2026.
Kaplan Fox & Kilsheimer LLP Alerts Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) to an Investigation of Potential Securities Law Violations
Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations after a former executive filed a whistleblower complaint. The complaint alleges accounting irregularities that artificially inflated the Company's financial results and executive compensation by misclassifying millions in operating expenses as capital expenditures. Following this news, Alignment Healthcare's stock price dropped significantly on July 8, 2026.
Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring A Potential 69% Upside
Alignment Healthcare, Inc. (ALHC), a healthcare plans provider for seniors, shows potential for a 69% upside according to analyst ratings. Despite recent stock volatility and a bearish short-term technical outlook, the company boasts robust revenue growth and a strong return on equity. Its focus on the expanding Medicare Advantage market positions it favorably for future growth, making it a compelling case for investors focused on capital gains.
Is Alignment Healthcare (ALHC) Still Undervalued As Lawsuit Driven Accounting Questions Grow?
Alignment Healthcare (ALHC) is facing scrutiny due to a whistleblower lawsuit alleging misclassification of operating expenses, impacting its adjusted EBITDA. Despite a significant short-term stock price decline, a narrative suggests the company is 41.6% undervalued with a fair value of $24.92, based on aggressive growth and margin assumptions. However, another valuation framework suggests ALHC is currently trading at a steep premium, raising questions about execution risk.
Lowey Dannenberg, P.C. is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for Potential Violations of the Federal Securities Laws
Lowey Dannenberg, P.C. is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential federal securities law violations. This follows a whistleblower lawsuit alleging that Alignment manipulated its finances by misclassifying expenses to artificially inflate its adjusted EBITDA and boost its stock price. The allegations led to a significant drop in Alignment's stock, causing losses for shareholders.
ALIGNMENT HEALTHCARE INC : JP MORGAN CUTS TARGET PRICE TO $22 FROM $26
JP Morgan has lowered its target price for ALIGNMENT HEALTHCARE INC from $26 to $22. This news was reported by Reuters on August 4, 2026. The article provides a brief update on the analyst rating change for the healthcare company.
Kaplan Fox Reminds Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors of an Investigation Into Potential Securities Law Violations
Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations after a whistleblower alleged "accounting irregularities" that artificially inflated the company's financial results. This complaint, filed by a former executive, claims that millions in operating expenses were misclassified as capital expenditures, leading to a 16.7% drop in Alignment Healthcare's stock price on July 8, 2026. Investors who suffered losses are encouraged to contact Kaplan Fox for more information regarding this investigation.
Kaplan Fox Reminds Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors of an Investigation Into Potential Securities Law Violations
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. following allegations of accounting irregularities that "artificially inflated" the company's financial results. A former executive filed a whistleblower complaint claiming millions in operating expenses were misclassified as capital expenditures, leading to a 16.7% stock price drop on July 8, 2026. The law firm is encouraging investors who suffered losses to contact them for more information regarding the investigation.
Securities Fraud Investigation Into Alignment Healthcare,
Glancy Prongay Wolke & Rotter LLP is continuing its securities fraud investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) following a whistleblower lawsuit. The lawsuit, filed by a former executive, alleges that Alignment Healthcare manipulated its finances by misclassifying $8 million to $10 million in operating expenses as capital expenditures to artificially inflate its adjusted EBITDA. This news led to a 16% drop in Alignment's stock price on July 8, 2026, causing losses for investors.
Down 37.6% in 4 Weeks, Here's Why Alignment Healthcare (ALHC) Looks Ripe for a Turnaround
The provided content is a privacy consent page from Yahoo and does not contain any article text about Alignment Healthcare (ALHC). Therefore, it's impossible to summarize why the company might be ripe for a turnaround based on the given information. The content primarily focuses on cookie usage and privacy choices.
Raymond James downgrades Alignment Healthcare stock rating on earnings visibility concerns
Raymond James downgraded Alignment Healthcare (NASDAQ:ALHC) to Outperform from Strong Buy and lowered its price target due to concerns about earnings visibility as the company expands into new markets. While Q2 2026 earnings beat expectations and the full-year guide was raised, increased investment spend and pressure on MLR from new members are impacting predictability. Despite a recent stock plunge and near-term uncertainty, InvestingPro analysis suggests the shares are undervalued, and the company holds more cash than debt with expected net income growth.
ALHC Stock Drops As Whistleblower Probe Sparks Legal Scrutiny
Alignment Healthcare Inc. (ALHC) stock dropped significantly by 18.66% following a whistleblower lawsuit alleging the company misclassified $8–$10 million in expenses as capital expenditures to inflate Adjusted EBITDA. Several law firms have initiated investigations into potential securities law violations, posing material regulatory and governance risks. The article details the financial overview, analyst sentiment, and technical analysis, suggesting a continued downtrend for the stock until the investigations are resolved.
Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Alignment Healthcare (ALHC) and McKesson (MCK)
Analysts from Bank of America Securities have issued bullish sentiments on three healthcare companies: Stryker (SYK), Alignment Healthcare (ALHC), and McKesson (MCK). Stryker received a Buy rating with a $380.59 price target, implying a 15.3% upside. Alignment Healthcare also garnered a Buy rating and a $23.20 price target, suggesting a 49.7% upside, while McKesson was maintained at a Buy rating with a $937.09 average price target, indicating a 10.2% upside.
